
Research explores intensive blood pressure control for patients with chronic kidney disease
The benefits of intensive blood pressure shown in the Systolic Blood Pressure Intervention Trial (SPRINT) also helps patients with chronic kidney disease, according to new research led by Kaiser Permanente and Stanford University. The study was published in January 2025 in JAMA Network Open. The SPRINT ...
Featured News
Study highlights the impact of electronic media use on young people
Young people who frequently used electronic media, such as computers, television, and social media, had less physical activity, more stress, and modest cognitive challenges. The study was published ...
New study sheds light on incidence of IgA nephropathy
A recent Kaiser Permanente study described the incidence of IgA nephropathy, an autoimmune kidney disease, nationally, as well as among people of different race and ethnicities. The study was published ...
RSV vaccine protects older adults against severe illness
A new study by Kaiser Permanente has shown that the ABRYSVO respiratory syncytial virus vaccine is very effective in reducing emergency room visits and hospital stays due to RSV among older adults. ...
KPSC teams with Moderna, Pfizer-BioNTech to assess real-world effectiveness of COVID-19 vaccines
March 30, 2021Researchers from Kaiser Permanente Southern California are collaborating with Moderna and Pfizer-BioNTech, the makers of the 2 first authorized COVID-19 vaccines, to study their vaccines’ effectiveness in real-world settings in preventing the disease and reducing its severity. Questions these studies will evaluate range from how long protection lasts to how well vaccines perform against variants ...Read more...New CIRT research projects aim to improve care
March 30, 2021The Care Improvement Research Team has awarded funds for 7 new research projects led by Southern California Permanente Medical Group scientists and physician researchers on COVID-19 and other health topics to help improve the care physicians provide for their patients. “This kind of research provides important new evidence to our frontline clinicians,” said Nancy Gin, MD, ...Read more...5 questions for … Dr. Shireen Fatemi
March 30, 2021Shireen Fatemi, MD, FACE, FACP, is an endocrinologist at the Kaiser Permanente Panorama City Medical Center. She was recently named the 2020 Southern California Permanente Medical Group Physician Researcher of the Year. Dr. Fatemi is the chief of Endocrinology in the Department of Internal Medicine and former assistant area medical director at Panorama City. She ...Read more...Residents lead advances in understanding of “broken heart” syndrome
March 29, 2021Research led by internal medicine residents at the Kaiser Permanente Los Angeles Medical Center has surfaced new insights into Takotsubo syndrome, a condition that closely resembles a heart attack. Most importantly, the findings link beta-blocker treatment with improved clinical outcomes. This project began in 2019, when residents Christopher Lau, MD, Sarah Chiu, MD, and Rohith Nayak, ...Read more...Diabetic eye damage reflects future cardiovascular risks
March 29, 2021People with type 2 diabetes may develop diabetic retinopathy, an eye condition that can lead to vision loss. Now, a study of over 77,000 Kaiser Permanente Southern California members shows that greater severity of diabetic retinopathy is strongly associated with a higher risk of heart attacks, strokes, congestive heart failure, and death from any cause. “Preventive ...Read more...Pneumonia vaccine may affect course of COVID-19
March 10, 2021One type of pneumonia vaccine, the PCV13 vaccine, may affect the course of COVID-19 for some older adult patients, new research shows. The Kaiser Permanente study was published in The Journal of Infectious Diseases. “Kaiser Permanente members who received the PCV13 vaccine appeared to be diagnosed with COVID-19 less often, and when they were, they seemed ...Read more...Dr. Fatemi named 2020 Researcher of the Year
March 9, 2021Shireen Fatemi, MD, FACE, FACP, an endocrinologist at Kaiser Permanente Panorama City Medical Center, has been named the 2020 Southern California Permanente Medical Group Researcher of the Year. The award has been given each year since 2007 to recognize a physician or surgeon for his or her outstanding contributions to the research community. Dr. Fatemi ...Read more...Scientists and physicians continue to research COVID-19 risks and outcomes
March 3, 2021As the COVID-19 pandemic wears on, researchers and physicians at Kaiser Permanente Southern California are analyzing the data collected and lessons learned over the first year of the pandemic to find better ways to test, treat, and care for patients. On January 26, a few of the researchers and scientists shared their latest projects at a ...Read more...Five questions for … Dr. Kristen Choi
March 3, 2021Kristen Choi, PHD, MS, RN, is a child/adolescent psychiatric nurse and health services researcher who is also an adjunct investigator with the Department of Research & Evaluation. She is an assistant professor at the UCLA School of Nursing and associate director of nursing for the UCLA National Clinician Scholars Program. Dr. Choi studies health services ...Read more...Researchers examine association of preterm birth and chemicals in flame-retardant fabrics
March 3, 2021A Kaiser Permanente Southern California study of 3,500 women showed that pregnant women with high levels of PDBE-47, a chemical used in flame-retardant fabrics, were at increased risk of giving birth early in the pregnancy. The study, “Women with high plasma levels of PBDE-47 are at increased risk of preterm birth” was published recently in the ...Read more...